MG - investor #ELIX Investors' Chronicle has given the thumbs up. "On 15.8 times forward earnings, Elixirr trades at a double-digit discount to its much larger rival Accenture (US:ACN). Buy." investorschronicle.co.uk/content/2e6dfd…

Diaceutics HY25 in line with expectations as it is 40:60 split. Promises to reach breakeven at PBT level for FY. They have always delivered what they promised so I have confidence they'll continue. #DXRX Broker had an interesting tidbit: "Diaceutics' customer base remains

Begbies Traynor internal Group CEO appointment: #BEG - makes sense

'feoh'ing hell Rodney what were they thinking? #CARR #FEOH

Diaceutics are presenting over zoom at 2:30pm BST today. You can register here: us06web.zoom.us/webinar/regist… #DXRX

Made Tech FY25 results showing solid progress #MTEC: Outlook: Very happy with that. I expect upgrades as year progresses. If you look at #MTEC recent history they have won very large contracts & I see no reason for this not to continue. Bowly chart for those who get excited by

Redcentric FY25 results are ok BUT it's the imminent disposal of the DC business which got me interested as a SOTP play: So #RCN is currently valued at ~£250m EV & the DC business should fetch ~£116m-£144m. The bulk of that I expect to be returned to shareholders, reduction in

Made Tech presentation for yesterday's results is now available here: piworld.co.uk/company-videos… #MTEC Thank you Progressive Equity

So fellow Brits how did you end up with a mandatory ID card? All the finger pointing at everyone except those who were controlling the narrative. Ready for a rant? Create chaos first. People begin to feel unsafe, insecure, unstable. They grow hopeless, despondent and fed up.

#BOKU interims continue to show very strong organic growth: and the outlook confirms that this is to continue: Share price near ATH's. No other comment from me really. I hold.

#NIOX interims once again show solid organic growth. Simple businesses are always the best ones: Outlook is sparkling too: Although I think they will beat current forecasts very comfortably. I feel like I'm repeating myself here #BOKU I hold.

#RWS CFO is to leave end of this year. In fairness she had a tough time. CEO actually started this year. I think this is a good move. But let's see who we get. I hold

It's the risk you don't see that should worry you courtesy of Graham Neary from Stockopedia I agree - All it will take is any one of the MAG7 not performing. Everything has a price. Are the MAG7 priced right?